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Article 16

Developing Gene Therapy
Researchers at the University of Pennsylvania
School of Veterinary Medicine are te:mng methods
for transferring normal genes into the cells of
animals affected by enzyme deficiencies that cause
severe and often fatal disorders in borh humans and
animals.
The en.cyme deficiency diseases, called
mucopolysaccharidoses, or MPS diseases, are
progressive degenerative disorders ol children and
young animals usually characterized by ..evere bone
abnormalities, heart defects, impaired vis1on. mental
retardation. and premature death. The diseases are
caused by deficiencies in enzymes whose normal
function is to break down specific molecules m the
ceU.
The curren1 research at Penn has focused on
developing and testing vectors. or carriers, that can
�uccessfully deliver healthy enzyme genes into MPS
affected cells.
In a presentation in Washington, D.C. at the
American Veterinary Medical Association
conference on genetic engineering, Dr. John Wolfe
of the Gene Therapy Research Group at Penn said
the group had developed a vector that is an effective
�-:arricr for one of the healthy genes. When
transferred, the gene corrected the abnormalities of
the diseased cell.
''The preliminary tests indicate that retroviral
vector gene transfer may be a feasible approach for
treating MPS diseases," Wolfe said.
Rctro'iral vectors acr as a delivery y�tcm for
placing the normal gene into the diseased cell.
Rctroviru�e� have proven to be good �;a11 ie1�. \Volfe
said, becau'c the� are capable of in�cs11ng the gene
into the DNA of the hosL cell, and they arc rclauvely
.simple viruo;es that have been exterui\ely modified so
th�y do not harm the cells in whlcb they are placed.
The initial testing, which has taken place within the
last si:\ to eight months, has been performed in tissue
culture using diseased cells from animals affected

Equine Symposium
for Students
Student!> organized an all-day equine !>ymposium.
consisting of hands·on demonstratiOn!> and lectures
on November 19. The topic$ offered in the
presentations and laboratories were: familiarization
with the Y AG Laser; cytology; cardiology and useful
equipment; semen handling and processing: embryo
tran:>fcr; marc reproductive tract: oblique
radiographs for common equine problems; neonatal
mten!>ive care; lameness diagnosis; principles of
internal fixation: to" power laser and acupuncture:
diagno!.uc ultrasound of the equine limb; colic; and
enc.lo copy. In the afternoon a lecture on the
prcpurcha!>C exam and its legal implicauons was
presemed. The following clinicians and tesJdcnts
participated and volunteered their t1mc for event: Dr.
Eric Tulleners. Dr. Ellen Ziemer, Dr. Johanna
Reimer, Dr. Charles Love, Dr. Patricia Sertich, Dr.
Martin Burton, Dr. Curtis Scbelling, Dr. Wendy
Vaala, Dr. Dan Dreyfuss, Dr. James Orsini, Dr.
Uenson Martin, Dr. Virginia Reef, Dr. JaneL
Johnston. Or. Alan Ruggles, Dr. Yvc'> Rossier. Dr.
Lm 1-.lcm, Dr. William \ioyer, and Dr. James
Wilson.
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with an MPS disorder, Wolfe said. The newly
developed vectors have been able to transfer the gene
to MPS cells. where the transferred gene has
corrected the defect in the diseased cells.
The work at Penn has been performed in
collaboration with the Memonal Sloan-Kettering
Cancer Center and the Mt. Sinai School of Medicine
in New York.
The next step, Wolfe said, will be to begin testing
to determine if the vectors can be transferred to and
function in diseased animals to actually alter the
course of the disease.
Although �1PS disorders are quite rare in the
general population, they often occur with high
frequency w1thin families that carry the defective
gene. Beside� the .MPS disorders. there are several
thousand other fonns of genetic d1sease. Effective
treatments are available now for only a few of those
disorders. Mauy researchers believe lhe new field of
gene therapy research offers an approach to the
treatment of previously incurable geneuc disorders of
animals and humans.
ln gene therapy, Wolfe explained. cells are
removed from the patient and placed into tiss\IC
culture; the normal gene is inserted; and the
t--orreeted cells arc returned to the patient.
''It IS replacing something that is m1ssing from the
ceU," Wolfe �aid. "ln effect, it is similar to giving
insulin for the treatment of diabetes. However,
unli�e insulin, the effect of the gene therapy
treatment would be permanent."
Researchers face several challenges in achieving
..u�'\:�,.,rul 11enc therapy The:- gc:nt In'olvecl in the
di'oease muM be tdentified- "!ll(:h ha:. not ye1 been
accomplished for many genetic diseases: the gene
must be cloned. or duplicated; an effective vector, or
delivery syc;tem, must be constructed to transfer the
ne" gene into the diseased ceUs; the vector must be
capable of transferring the gene to the correct target
cell; the transferred gene must function correctly

Dog �ith MPS Vll

once it reaches the diseased cell: and, linally. the
transferred gene must be able to cure or substant1all)
aller the course of the diseru;e for gene therapy to be
considered successful.
The MPS dise�es are good subjects for gene
therapy research because the def�tive genes have
been identifietl and can be duplicated. And, Wolfe
said. since the MPS diseases that occur u'l ammals are
very similar to those that occur in humans. what ts
learned from studying the MPS affected animals
should be highly applicable to treating the diseases in
humans.
This is a good example of reciprocal benet;: tn
hurnan and ammal medicine," \\'olfe satd. MPS "'as
first discovered in humans, and that led to its
discm.:cry in animals.
• 'The information and benefits no" back and
forth between animal and human medicine.''
·

Phyllis Holtzman

SCAVMA Activities
The second annual Student Teadung r\\\ards
Dinner will be held on Sunday, Apnl 2, 1989, 6:00
pm at the Hotel DuPont in Wilmington, DE- Tickets
will be $17.00each for students and $30 OOeach for
faculty. Look for Lhe invitations in the mail. Last
year 200 students and 150 faculty, staff and alumni
attended 1 he dinner at Longwood Gardens. AU
enjoyed the feast and ceremonies and are looking
forward to this year's everu.
SCA \ MA 's annual December auction exceeded a1J
expectations. Support was tremendous. $9,000 were
raised. The funds will be used b� the faculty/
SCAV\1A fund to provide money tor the student
emergency loan fund. Part of the proceeds will help
defray the cost of student tickets to the Dinner
Dance.
Bigger and better than ever-SCAVMA 's latest
fund raising effort is a 'Boutique' in the student
lounge. It offers a great selection of sweatshirts,
sweatpants, T·sbirts, jogging short!>, mugs and can
coolers-available in a variety of colors and graphic
d�igns. AJso beginning in January, merchandise will
be available at New Bohon Center in the cafeteria on
rridays.
This year's SCA VMA student sympo.s1um will be
held at North Carolina State University, in Raleigh
Durham. Approximately 80 students from Penn will
participate in the event. Funds raised by SCAVMA
throughout the year will be used to defray the coStS
of transportation and accomodations.

